The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
April 25th 2025
New research reveals how high blood sugar from type 2 diabetes alters brain function, mimicking early Alzheimer symptoms and impacting memory.
Low Immunity Linked to Poor Outcomes in Patients with HIV, COVID-19
January 13th 2021As patients with HIV are living longer, they are also being diagnosed with chronic conditions that have become increasingly common in recent decades, putting them at higher risk of COVID-19 hospitalization and death.
Read More
Planning, Implementing Walgreens’ COVID-19 Vaccination Program at Long-term Care Facilities
January 13th 2021Pharmacy Times® interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on the first wave of COVID-19 vaccine administration at long-term care facilities across the country.
Watch
Researchers from the University of Texas MD Anderson Cancer Center found that men with localized prostate cancer who reported a baseline dietary pattern that more closely follows the key principles of a Mediterranean-style diet fared better over the course of their disease.
Read More
Monoclonal Antibodies Show Promise Treating COVID-19
There is particular interest in monoclonal antibody agents to determine whether their immune suppressive effects can reduce the immediate and long-term impact of COVID-19.
Read More
Study: Biologic Therapy for Psoriasis May Reduce Heart Disease
January 12th 2021The current study provides characterization of a lipid-rich necrotic core, a dangerous type of coronary plaque made up of dead cells and cell debris that is prone to rupture, which can lead to a heart attack or stroke.
Read More
Supreme Court Ruling May Open the Door for More Widespread Legislation Limiting Power of PBMs
January 11th 2021Katea Ravega, a partner at Quarles and Brady LLP, discussed the recent Supreme Court ruling in Rutledge v. PCMA and what it could mean for the future of states’ legislation around PBMs.
Read More
Physician-Pharmacist Collaboration May Increase Adherence to Opioid Addiction Treatment
January 11th 2021A pilot study published today in Addiction found that a collaborative approach to treating opioid use disorder that relies heavily on community pharmacists is feasible and may increase adherence and participant satisfaction.
Read More
Facebook Posts Help Facilitate Belief that HPV Vaccine is Dangerous to Health
January 11th 2021When examining the percentage of posts that made the vaccine seem more dangerous, less dangerous, or neither, Luisi found nearly 40% of Facebook posts about the HPV vaccine amplified a perceived risk.
Read More
The Enforcement of 340B Drug Pricing Laws May Change Under the Biden Administration
January 8th 2021Pharmacy Times® interviewed William von Oehsen, JD, principal at Powers Pyles Sutter & Verville, on a letter that was signed by President-elect Biden’s pick for HHS secretary to the outgoing HHS secretary on the enforcement of 340B drug pricing laws.
Watch
Pharmacists Are Moderately Satisfied With Compensation, Job Satisfaction, Survey Shows (Part 2)
January 8th 2021The first article in this 3-part series covered a general overview of the survey and its respondents. In this article, we will explore the questions and answers around compensation.
Read More
Short Videos Can Be Effective for Improving Medication Adherence
January 8th 2021Patrick Campbell, PharmD, PhD, the senior director of research at the Pharmacy Quality Alliance, discusses why sending a short video to a patient’s phone can improve primary medication adherence and why it’s more effective than text messages.
Watch
Pharmacist Burnout: A Cry for a Transformative Approach to Traditional Pharmacy Practice
January 7th 2021Pharmacists must juggle the delicate balance of integrating clinical services into traditional dispensing environments, while being forced into performance metrics set forth by corporate entities.
Read More
Government’s Unwillingness to Act on 340B Drug Pricing Affects Patients at the Pharmacy Counter
January 7th 2021Pharmacy Times® interviewed William von Oehsen, JD, principal at Powers Pyles Sutter & Verville, on how pharmacies and their patients are affected by issues regarding the regulation of the sale of 340B discounted drugs.
Watch